291 related articles for article (PubMed ID: 24145681)
1. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment.
Ali S; Chen JA; Garcia JM
Curr Opin Support Palliat Care; 2013 Dec; 7(4):368-75. PubMed ID: 24145681
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.
Akamizu T; Kangawa K
Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin as a Promising Therapeutic Option for Cancer Cachexia.
Khatib MN; Gaidhane A; Gaidhane S; Quazi ZS
Cell Physiol Biochem; 2018; 48(5):2172-2188. PubMed ID: 30110683
[TBL] [Abstract][Full Text] [Related]
4. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
5. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
6. Acylated and unacylated ghrelin administration to blunt muscle wasting.
Reano S; Graziani A; Filigheddu N
Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):236-40. PubMed ID: 24572833
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
Conte E; Camerino GM; Mele A; De Bellis M; Pierno S; Rana F; Fonzino A; Caloiero R; Rizzi L; Bresciani E; Ben Haj Salah K; Fehrentz JA; Martinez J; Giustino A; Mariggiò MA; Coluccia M; Tricarico D; Lograno MD; De Luca A; Torsello A; Conte D; Liantonio A
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):386-404. PubMed ID: 28294567
[TBL] [Abstract][Full Text] [Related]
8. Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis.
Meanti R; Bresciani E; Rizzi L; Coco S; Zambelli V; Dimitroulas A; Molteni L; Omeljaniuk RJ; Locatelli V; Torsello A
Curr Neuropharmacol; 2023; 21(12):2376-2394. PubMed ID: 36111771
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.
Garcia JM; Friend J; Allen S
Support Care Cancer; 2013 Jan; 21(1):129-37. PubMed ID: 22699302
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
[TBL] [Abstract][Full Text] [Related]
11. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.
Wang W; Andersson M; Iresjö BM; Lönnroth C; Lundholm K
Int J Oncol; 2006 Jun; 28(6):1393-400. PubMed ID: 16685441
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin: from discovery to cancer cachexia therapy.
Molfino A; Formiconi A; Rossi Fanelli F; Muscaritoli M
Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):471-6. PubMed ID: 24905862
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
14. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
15. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
Graf SA; Garcia JM
Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of ghrelin in the field of surgery.
Takiguchi S; Murakami K; Yanagimoto Y; Takata A; Miyazaki Y; Mori M; Doki Y
Surg Today; 2015 Jul; 45(7):801-7. PubMed ID: 25366350
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ghrelin in cancer cachexia: clinical trials and a novel treatment by rikkunshito.
Fujitsuka N; Asakawa A; Amitani H; Hattori T; Inui A
Crit Rev Oncog; 2012; 17(3):277-84. PubMed ID: 22831158
[TBL] [Abstract][Full Text] [Related]
18. Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia.
Torres-Fuentes C; Pastor-Cavada E; Cano R; Kandil D; Shanahan R; Juan R; Shaban H; McGlacken GP; Schellekens H
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848961
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.
Deboer MD; Zhu X; Levasseur PR; Inui A; Hu Z; Han G; Mitch WE; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL
Endocrinology; 2008 Feb; 149(2):827-35. PubMed ID: 18039782
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
Cheung WW; Mak RH
Kidney Int; 2009 Jul; 76(2):135-7. PubMed ID: 19564855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
